Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392]

Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, Parham Rahmanian, Sareh Sadat Shafiee, Melina Maghsodlou Nejad, Roghayeh Babaei, Farzaneh Hasani Sadi, Romina Rajabi, Zahra Oryan Abkenar, Shamin Rezaei, Jun Ren, Noushin Nabavi, Ramin Khorrami, Mohsen Rashidi, Kiavash Hushmandi, Maliheh Entezari, Afshin Taheriazam

Open source

DOI: 10.1016/j.biopha.2026.119216
Published: 2026-05
Container: Biomedicine & Pharmacotherapy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119216,
  title = {Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine \&amp; Pharmacotherapy 160 (2023) 114392]},
  author = {Mehrdad Hashemi and Mohammad Arad Zandieh and Yasmin Talebi and Parham Rahmanian and Sareh Sadat Shafiee and Melina Maghsodlou Nejad and Roghayeh Babaei and Farzaneh Hasani Sadi and Romina Rajabi and Zahra Oryan Abkenar and Shamin Rezaei and Jun Ren and Noushin Nabavi and Ramin Khorrami and Mohsen Rashidi and Kiavash Hushmandi and Maliheh Entezari and Afshin Taheriazam},
  year = {2026},
  journal = {Biomedicine \&amp; Pharmacotherapy},
  doi = {10.1016/j.biopha.2026.119216},
  url = {https://doi.org/10.1016/j.biopha.2026.119216}
}

RIS

TY  - JOUR
TI  - Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine &amp; Pharmacotherapy 160 (2023) 114392]
AU  - Mehrdad Hashemi
AU  - Mohammad Arad Zandieh
AU  - Yasmin Talebi
AU  - Parham Rahmanian
AU  - Sareh Sadat Shafiee
AU  - Melina Maghsodlou Nejad
AU  - Roghayeh Babaei
AU  - Farzaneh Hasani Sadi
AU  - Romina Rajabi
AU  - Zahra Oryan Abkenar
AU  - Shamin Rezaei
AU  - Jun Ren
AU  - Noushin Nabavi
AU  - Ramin Khorrami
AU  - Mohsen Rashidi
AU  - Kiavash Hushmandi
AU  - Maliheh Entezari
AU  - Afshin Taheriazam
PY  - 2026
JO  - Biomedicine &amp; Pharmacotherapy
DO  - 10.1016/j.biopha.2026.119216
UR  - https://doi.org/10.1016/j.biopha.2026.119216
ER  -

APA

Hashemi, M., Zandieh, M. A., Talebi, Y., Rahmanian, P., Shafiee, S. S., Nejad, M. M., Babaei, R., Sadi, F. H., Rajabi, R., Abkenar, Z. O., Rezaei, S., Ren, J., Nabavi, N., Khorrami, R., Rashidi, M., Hushmandi, K., Entezari, M., & Taheriazam, A. (2026). Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392]. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119216

Source records

crossref · retrieved 2026-09-26T16:46:12.723Z

Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine &amp; Pharmacotherapy 160 (2023) 114392]

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records

Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392]